Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Sep 21:374:n2132.
doi: 10.1136/bmj.n2132.

Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial

Loïc Lhopitallier  1 , Andreas Kronenberg  2   3 , Jean-Yves Meuwly  4 , Isabella Locatelli  5 , Yolanda Mueller  6 , Nicolas Senn  6 , Valérie D'Acremont  5   7   8 , Noémie Boillat-Blanco  9
Affiliations
Randomized Controlled Trial

Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial

Loïc Lhopitallier et al. BMJ. .

Abstract

Objective: To assess whether point-of care procalcitonin and lung ultrasonography can safely reduce unnecessary antibiotic treatment in patients with lower respiratory tract infections in primary care.

Design: Three group, pragmatic cluster randomised controlled trial from September 2018 to March 2020.

Setting: 60 Swiss general practices.

Participants: One general practitioner per practice was included. General practitioners screen all patients with acute cough; patients with clinical pneumonia were included.

Interventions: Randomisation in a 1:1:1 of general practitioners to either antibiotics guided by sequential procalcitonin and lung ultrasonography point-of-care tests (UltraPro; n=152), procalcitonin guided antibiotics (n=195), or usual care (n=122).

Main outcomes: Primary outcome was proportion of patients in each group prescribed an antibiotic by day 28. Secondary outcomes included duration of restricted activities due to lower respiratory tract infection within 14 days.

Results: 60 general practitioners included 469 patients (median age 53 years (interquartile range 38-66); 278 (59%) were female). Probability of antibiotic prescription at day 28 was lower in the procalcitonin group than in the usual care group (0.40 v 0.70, cluster corrected difference -0.26 (95% confidence interval -0.41 to -0.10)). No significant difference was seen between UltraPro and procalcitonin groups (0.41 v 0.40, -0.03 (-0.17 to 0.12)). The median number of days with restricted activities by day 14 was 4 days in the procalcitonin group and 3 days in the usual care group (difference 1 day (95% confidence interval -0.23 to 2.32); hazard ratio 0.75 (95% confidence interval 0.58 to 0.97)), which did not prove non-inferiority.

Conclusions: Compared with usual care, point-of-care procalcitonin led to a 26% absolute reduction in the probability of 28 day antibiotic prescription without affecting patients' safety. Point-of-care lung ultrasonography did not further reduce antibiotic prescription, although a potential added value cannot be excluded, owing to the wide confidence intervals.

Trial registration: ClinicalTrials.gov NCT03191071.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the Swiss National Science Foundation and the Leenaards Foundation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
Consort flowchart of trial participants. COPD=chronic obstructive pulmonary disease
Fig 2
Fig 2
Probability (%) of antibiotic prescription by days 0, 7, and 28 according to study group (usual care, procalcitonin, and UltraPro (sequential procalcitonin and lung ultrasonography point-of-care tests))
See this image and copyright information in PMC

References

    1. Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat 13 2006;(159):1-66. - PubMed
    1. Woodhead M, Blasi F, Ewig S, et al. Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases . Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect 2011;17(Suppl 6):E1-59. 10.1111/j.1469-0691.2011.03672.x. - DOI - PMC - PubMed
    1. Huchon GJ, Gialdroni-Grassi G, Léophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 1996;9:1590-5. 10.1183/09031936.96.09081590 - DOI - PubMed
    1. Cals JW, Hopstaken RM, Butler CC, Hood K, Severens JL, Dinant GJ. Improving management of patients with acute cough by C-reactive protein point of care testing and communication training (IMPAC3T): study protocol of a cluster randomised controlled trial. BMC Fam Pract 2007;8:15. 10.1186/1471-2296-8-15. - DOI - PMC - PubMed
    1. Anthierens S, Tonkin-Crine S, Cals JW, et al. GRACE/CHAMP INTRO team . Clinicians’ views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infections. J Gen Intern Med 2015;30:408-16. 10.1007/s11606-014-3076-6. - DOI - PMC - PubMed

Publication types

Associated data